NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
48 hedge funds and large institutions have $123M invested in NKGen Biotech, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.42M | |
| 2 | +$3.23M | |
| 3 | +$2.48M | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
+$1.59M |
| 5 |
EAM
Exos Asset Management
New York
|
+$699K |